An Adeno-Associated Virus-Based Intracellular Sensor of Pathological Nuclear Factor-κB Activation for Disease-Inducible Gene Transfer

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Chtarto, Abdelwahed ^a   Bockstael, Olivier ^a   Gebara, Elias ^b   Vermoesen, Katia ^c   Melas, Catherine ^a   Pythoud, Catherine ^d   Levivier, Marc ^d   de Witte, Olivier ^a   Luthi Carter, Ruth ^b   Clinkers, Ralph ^c   Tenenbaum, Liliane ^d  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b EPFL   (Switzerland)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CELL; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; EPILEPTIC STATE; FETUS; GENE EXPRESSION; GENE INDUCTION; GENE TRANSFER; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR GENE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR PATHOLOGY; NONHUMAN; POLYOMA VIRUS; RAT; TEMPORAL LOBE EPILEPSY;

ANIMALS; CELL AGING; CENTRAL NERVOUS SYSTEM; CEREBRAL CORTEX; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; MALE; MICE; NEURONS; NF-KAPPA B; PROMOTER REGIONS, GENETIC; RATS; RATS, WISTAR; STATUS EPILEPTICUS; TRANSGENES;

ADENO-ASSOCIATED VIRUS; POLYOMAVIRUS; RATTUS;

EID: 84871908609     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053156     Document Type: Article

References (72)

1. Fluri DA, Baba MD, Fussenegger M, (2007) Adeno-associated viral vectors engineered for macrolide-adjustable transgene expression in mammalian cells and mice. BMC Biotechnol 7: 75.
2. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, et al. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766-1769.
3. Adriaansen J, Khoury M, de Cortie CJ, Fallaux FJ, Bigey P, et al. (2007) Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent. Ann Rheum Dis 66: 1143-1150.
4. Jakobsson J, Georgievska B, Ericson C, Lundberg C, (2004) Lesion-dependent regulation of transgene expression in the rat brain using a human glial fibrillary acidic protein-lentiviral vector. Eur J Neurosci 19: 761-765.
5. Phillips MI, Tang Y, Schmidt-Ott K, Qian K, Kagiyama S, (2002) Vigilant vector: heart-specific promoter in an adeno-associated virus vector for cardioprotection. Hypertension 39: 651-655.
6. Siebenlist U, Franzoso G, Brown K, (1994) Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol. 10: 405-455.
7. Karin M, Delhase M, (2000) The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 12: 85-98.
8. Kaltschmidt B, Widera D, Kaltschmidt C, (2005) Signaling via NF-kappaB in the nervous system. Biochim Biophys Acta 1745: 287-299.
9. Lubin FD, Johnston LD, Sweatt JD, Anderson AE, (2005) Kainate mediates nuclear factor-kappa B activation in hippocampus via phosphatidylinositol-3 kinase and extracellular signal-regulated protein kinase. Neuroscience 133: 969-981.
10. Lubin FD, Ren Y, Xu X, Anderson AE, (2007) Nuclear factor-kappa B regulates seizure threshold and gene transcription following convulsant stimulation. J Neurochem 103: 1381-1395.
11. Ben Ari Y, (1985) Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14: 375-403.
12. Cavalheiro EA, Leite JP, Bortolotto ZA, Turski WA, Ikonomidou C, et al. (1991) Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia 32: 778-782.
13. Lothman EW, Bertram EH, Kapur J, Stringer JL, (1990) Recurrent spontaneous hippocampal seizures in the rat as a chronic sequela to limbic status epilepticus. Epilepsy Res 6: 110-118.
14. Vincent P, Mulle C, (2009) Kainate receptors in epilepsy and excitotoxicity. Neuroscience 158: 309-323.
15. Bouilleret V, Ridoux V, Depaulis A, Marescaux C, Nehlig A, et al. (1999) Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy. Neuroscience 89: 717-729.
16. Hellier JL, Patrylo PR, Buckmaster PS, Dudek FE, (1998) Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy. Epilepsy Res 31: 73-84.
17. Majores M, Eils J, Wiestler OD, Becker AJ, (2004) Molecular profiling of temporal lobe epilepsy: comparison of data from human tissue samples and animal models. Epilepsy Res 60: 173-178.
18. Ravizza T, Balosso S, Vezzani A, (2011) Inflammation and prevention of epileptogenesis. Neurosci Lett 497: 223-230.
19. Stafstrom CE, Thompson JL, Holmes GL, (1992) Kainic acid seizures in the developing brain: status epilepticus and spontaneous recurrent seizures. Brain Res Dev Brain Res 65: 227-236.
20. Gemma C, Mesches MH, Sepesi B, Choo K, Holmes DB, et al. (2002) Diets enriched in foods with high antioxidant activity reverse age-induced decreases in cerebellar beta-adrenergic function and increases in proinflammatory cytokines. J Neurosci 22: 6114-6120.
21. Tarkowski E, Liljeroth AM, Minthon L, Tarkowski A, Wallin A, et al. (2003) Cerebral pattern of pro- and anti-inflammatory cytokines in dementias. Brain Res Bull 61: 255-260.
22. Patel JR, Brewer GJ, (2008) Age-related differences in NFkappaB translocation and Bcl-2/Bax ratio caused by TNFalpha and Abeta42 promote survival in middle-age neurons and death in old neurons. Exp Neurol 213: 93-100.
23. Mattson MP, Meffert MK, (2006) Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ 13: 852-860.
24. Carlsen H, Moskaug JO, Fromm SH, Blomhoff R, (2002) In vivo imaging of NF-kappa B activity. J Immunol 168: 1441-1446.
25. Bhakar AL, Tannis LL, Zeindler C, Russo MP, Jobin C, et al. (2002) Constitutive nuclear factor-kappa B activity is required for central neuron survival. J Neurosci 22: 8466-8475.
26. Ranganathan PN, Khalili K, (1993) The transcriptional enhancer element, kappa B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS. Nucleic Acids Res 21: 1959-1964.
27. Wollebo HS, Safak M, Del VL, Khalili K, White MK, (2011) Role for tumor necrosis factor-alpha in JC virus reactivation and progressive multifocal leukoencephalopathy. J Neuroimmunol 233: 46-53.
28. Lesuisse C, Martin LJ, (2002) Immature and mature cortical neurons engage different apoptotic mechanisms involving caspase-3 and the mitogen-activated protein kinase pathway. J Cereb Blood Flow Metab 22: 935-950.
29. McCarty DM, Fu H, Monahan PE, Toulson CE, Naik P, et al. (2003) Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther 10: 2112-2118.
30. Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, et al. (1999) Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 6: 973-985.
31. Lock M, McGorray S, Auricchio A, Ayuso E, Beecham EJ, et al. (2010) Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material. Hum Gene Ther 21: 1273-1285.
32. Zala D, Benchoua A, Brouillet E, Perrin V, Gaillard MC, et al. (2005) Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment. Neurobiol Dis 20: 785-798.
33. Zabel U, Henkel T, Silva MS, Baeuerle PA, (1993) Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus. EMBO J 12: 201-211.
34. Vermoesen K, Smolders I, Massie A, Michotte Y, Clinckers R, (2010) The control of kainic acid-induced status epilepticus. Epilepsy Res 90: 164-166.
35. Vermoesen K, Massie A, Smolders I, Clinckers R (2012) The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy. Epilepsia 53: 870-878. 10.1111/j.1528-1167.2012.03436.x [doi].
36. Williams PA, White AM, Clark S, Ferraro DJ, Swiercz W, et al. (2009) Development of spontaneous recurrent seizures after kainate-induced status epilepticus. J Neurosci 29: 2103-2112.
37. Fu H, Muenzer J, Samulski RJ, Breese G, Sifford J, et al. (2003) Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain. Mol Ther 8: 911-917.
38. McCarty DM, Monahan PE, Samulski RJ, (2001) Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther 8: 1248-1254.
39. Afione SA, Conrad CK, Kearns WG, Chunduru S, Adams R, et al. (1996) In vivo model of adeno-associated virus vector persistence and rescue. J Virol 70: 3235-3241.
40. Haberman RP, McCown TJ, Samulski RJ, (2000) Novel transcriptional regulatory signals in the adeno-associated virus terminal repeat A/D junction element. J Virol 74: 8732-8739.
41. Eggermont J, Proudfoot NJ, (1993) Poly(A) signals and transcriptional pause sites combine to prevent interference between RNA polymerase II promoters. EMBO J 12: 2539-2548.
42. Chtarto A, Bender HU, Hanemann CO, Kemp T, Lehtonen E, et al. (2003) Tetracycline-inducible transgene expression mediated by a single AAV vector. Gene Ther 10: 84-94.
43. Strathdee CA, McLeod MR, Hall JR, (1999) Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector. Gene 229: 21-29.
44. Channavajhala PL, Rao VR, Spaulding V, Lin LL, Zhang YG, (2005) hKSR-2 inhibits MEKK3-activated MAP kinase and NF-kappaB pathways in inflammation. Biochem Biophys Res Commun 334: 1214-1218.
45. Boshart M, Weber F, Jahn G, Dorsch-Hasler K, Fleckenstein B, et al. (1985) A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41: 521-530.
46. Howard DB, Powers K, Wang Y, Harvey BK (2008) Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro. Virology 372: 24-34. S0042-6822(07)00658-7 [pii];10.1016/j.virol.2007.10.007 [doi].
47. Somera-Molina KC, Nair S, Van Eldik LJ, Watterson DM, Wainwright MS (2009) Enhanced microglial activation and proinflammatory cytokine upregulation are linked to increased susceptibility to seizures and neurologic injury in a 'two-hit' seizure model. Brain Res 1282: 162-172. S0006-8993(09)01093-2 [pii];10.1016/j.brainres.2009.05.073 [doi].
48. Rong Y, Baudry M, (1996) Seizure activity results in a rapid induction of nuclear factor-kappa B in adult but not juvenile rat limbic structures. J Neurochem 67: 662-668.
49. Verma IM, (2004) Nuclear factor (NF)-kappaB proteins: therapeutic targets. Ann Rheum Dis 63 (Suppl 2):: ii57-ii61.
50. Depino AM, Earl C, Kaczmarczyk E, Ferrari C, Besedovsky H, et al. (2003) Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease. Eur J Neurosci 18: 2731-2742.
51. Tansey MG, Goldberg MS, (2010) Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 37: 510-518.
52. Caba E, Bahr BA, (2004) Biphasic NF-kappaB activation in the excitotoxic hippocampus. Acta Neuropathol 108: 173-182.
53. Emborg ME, Moirano J, Raschke J, Bondarenko V, Zufferey R, et al. (2009) Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF. Neurobiol Dis 36: 303-311.
54. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F, (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132.
55. Jankowsky JL, Derrick BE, Patterson PH, (2000) Cytokine responses to LTP induction in the rat hippocampus: a comparison of in vitro and in vivo techniques. Learn Mem 7: 400-412.
56. Oprica M, Eriksson C, Schultzberg M, (2003) Inflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin-1 system. J Cell Mol Med 7: 127-140.
57. Turrin NP, Rivest S, (2004) Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy. Neurobiol Dis 16: 321-334.
58. Vezzani A, Granata T, (2005) Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46: 1724-1743.
59. Vezzani A, Aronica E, Mazarati A, Pittman QJ (2011) Epilepsy and brain inflammation. Exp Neurol.
60. Lacaille JC, Mueller AL, Kunkel DD, Schwartzkroin PA, (1987) Local circuit interactions between oriens/alveus interneurons and CA1 pyramidal cells in hippocampal slices: electrophysiology and morphology. J Neurosci 7: 1979-1993.
61. Sheppard PW, Sun X, Emery JF, Giffard RG, Khammash M (2011) Quantitative characterization and analysis of the dynamic NF-kappaB response in microglia. BMC Bioinformatics 12: 276. 1471-2105-12-276 [pii];10.1186/1471-2105-12-276 [doi].
62. Blits B, Derks S, Twisk J, Ehlert E, Prins J, et al. (2010) Adeno-associated viral vector (AAV)-mediated gene transfer in the red nucleus of the adult rat brain: comparative analysis of the transduction properties of seven AAV serotypes and lentiviral vectors. J Neurosci Methods 185: 257-263.
63. Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, et al. (2004) Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 10: 302-317.
64. Taymans JM, Vandenberghe LH, Haute CV, Thiry I, Deroose CM, et al. (2007) Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Hum Gene Ther 18: 195-206.
65. Van der PA, Toelen J, Carlon M, Van den HC, Coun F, et al. (2011) Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2/1, 2/2, 2/5, 2/6.2, 2/7, 2/8 and 2/9. Gene Ther 18: 517-527.
66. Davidson BL, Stein CS, Heth JA, Martins I, Kotin RM, et al. (2000) Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci U S A 97: 3428-3432. 10.1073/pnas.050581197 [doi];050581197 [pii].
67. Koerber JT, Klimczak R, Jang JH, Dalkara D, Flannery JG, et al. (2009) Molecular evolution of adeno-associated virus for enhanced glial gene delivery. Mol Ther 17: 2088-2095. mt2009184 [pii];10.1038/mt.2009.184 [doi].
68. Bockstael O, Chtarto A, Wakkinen J, Yang X, Melas C, et al. (2008) Differential transgene expression profiles from rAAV2/1 vectors using the tetON and CMV promoters in the rat brain. Hum Gene Ther.
69. Haberman R, Criswell H, Snowdy S, Ming Z, Breese G, et al. (2002) Therapeutic liabilities of in vivo viral vector tropism: adeno-associated virus vectors, NMDAR1 antisense, and focal seizure sensitivity. Mol Ther 6: 495-500.
70. Bockstael O, Melas C, Pythoud C, Levivier M, McCarty D, et al. (2012) Rapid Transgene Expression in Multiple Precursor Cell Types of Adult Rat Subventricular Zone Mediated by Adeno-Associated Type 1 Vectors. Hum Gene Ther. 10.1089/hum.2011.216 [doi].
71. Reimsnider S, Manfredsson FP, Muzyczka N, Mandel RJ, (2007) Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the rat. Mol Ther 15: 1504-1511.
72. Zolotukhin S, Potter M, Hauswirth WW, Guy J, Muzyczka N, (1996) A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol 70: 4646-4654.